Association between Fasting Blood Sugar Levels and Psoriasis Severity using the PASI Score: A Single-Center Cross-Sectional Study
Journal of Medicine and Urban Health · 23.06.2026
DOI: 10.62691/jmuh.2026.7829 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Medicine and Urban Health, online erschienen am 23.06.2026. Verfasst von Ajiraya Saliddiphant und 4 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Psoriasis is a chronic immune-mediated inflammatory skin disease characterized by dry, thick, raised patches. The Psoriasis Area and Severity Index (PASI) measures disease severity body surface area and treatment efficacy. Psoriasis can increase the risk of diabetes and worsen insulin resistance, resulting in increased fasting blood sugar (FBS) and worsening diabetic symptoms. This study aimed to study the correlation between FBS and PASI score in psoriasis patients.Materials and Methods: This retrospective study analyzed the relationship between PASI scores and FBS levels in psoriasis patients who visited the Dermatology Outpatient Clinic between 2019 and 2023. PASI scores were assessed by dermatologists, and FBS levels collected within a month of PASI evaluation were analyzed. Patients were categorized into diabetes mellitus (DM) and non- diabetes mellitus (non-DM) groups. Those on systemic therapy or without FBS were excluded.
Results
Data from 65 psoriasis patients were analyzed (non-DM (n = 58), DM (n = 7)). The average PASI score was 8.4 (5.9, 10.9) in non-DM patients and 7 (2.7, 4) in DM patients, respectively. Mean FBS levels were evaluated based on PASI severity: mild (n = 36) - 109.4 (100.1, 118.8), moderate (n = 13) - 103.6 (95.9, 111.4), and severe (n = 16) - 96.8 (92.9, 100.6). Comparison of mean FBS across PASI severity categories showed no statistically significant differences (mild vs. moderate: mean difference 5.7 milligrams (mg)/ deciliter (dL), p = 0.416, 95% confidence interval (CI) −8.3 to 19.8; moderate vs. severe: mean difference 6.8 mg/dL, p = 0.402, 95% CI −9.4 to 23.1; mild vs. severe: mean difference 12.6 mg/dL, p = 0.058, 95% CI −0.4 to 25.7).
Conclusion
No significant correlation was found between FBS levels and PASI scores in either the DM or non-DM groups.
Zitieren
APA
Saliddiphant, A., Boonrith, N., Powichian, N., Leeyaphan, C., & Bunyaratavej, S. (2026). Association between Fasting Blood Sugar Levels and Psoriasis Severity using the PASI Score: A Single-Center Cross-Sectional Study. Journal of Medicine and Urban Health. https://doi.org/10.62691/jmuh.2026.7829
Vancouver
Saliddiphant A, Boonrith N, Powichian N, Leeyaphan C, Bunyaratavej S. Association between Fasting Blood Sugar Levels and Psoriasis Severity using the PASI Score: A Single-Center Cross-Sectional Study. Journal of Medicine and Urban Health. 2026. doi:10.62691/jmuh.2026.7829
BibTeX
@article{Saliddiphant2026,
author = {Saliddiphant, Ajiraya and Boonrith, Natnaphat and Powichian, Nontanee and Leeyaphan, Charussri and Bunyaratavej, Sumanas},
title = {Association between Fasting Blood Sugar Levels and Psoriasis Severity using the PASI Score: A Single-Center Cross-Sectional Study},
journal = {Journal of Medicine and Urban Health},
year = {2026},
doi = {10.62691/jmuh.2026.7829}
}
EUVIMED